1. Home
  2. FATE vs TCGL Comparison

FATE vs TCGL Comparison

Compare FATE & TCGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

113.8M

Sector

Health Care

ML Signal

HOLD

TCGL

TechCreate Group Ltd. Class A Ordinary Shares

N/A

Current Price

$5.83

Market Cap

109.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
FATE
TCGL
Founded
2007
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
113.8M
109.5M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
FATE
TCGL
Price
$1.07
$5.83
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$3.92
N/A
AVG Volume (30 Days)
1.5M
589.9K
Earning Date
11-13-2025
02-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,137,000.00
$2,580,927.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.80
52 Week Low
$0.66
$3.95
52 Week High
$1.94
$5.91

Technical Indicators

Market Signals
Indicator
FATE
TCGL
Relative Strength Index (RSI) 51.95 N/A
Support Level $0.97 N/A
Resistance Level $1.13 N/A
Average True Range (ATR) 0.06 0.00
MACD 0.01 0.00
Stochastic Oscillator 63.69 0.00

Price Performance

Historical Comparison
FATE
TCGL

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About TCGL TechCreate Group Ltd. Class A Ordinary Shares

TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.

Share on Social Networks: